-
1
-
-
0028150629
-
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
-
1. Allen-Mersh TG, Earlam S, Fordy C et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
-
(1994)
Lancet
, vol.344
, pp. 1255-1260
-
-
Allen-Mersh, T.G.1
Earlam, S.2
Fordy, C.3
-
2
-
-
0344051547
-
Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer
-
2. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J. Natl Cancer Inst. 1996; 88: 252-8.
-
(1996)
J. Natl Cancer Inst.
, vol.88
, pp. 252-258
-
-
-
3
-
-
0026625223
-
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective, randomized trial
-
3. Rougier P, Laplanche A, Hugier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective, randomized trial. J. Clin. Oncol. 1992; 10: 1112-18.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1112-1118
-
-
Rougier, P.1
Laplanche, A.2
Hugier, M.3
-
5
-
-
0026816276
-
Regression of liver metastases following treatment with Yttrium-90 microspheres
-
5. Gray BN, Anderson MA, Burton G et al. Regression of liver metastases following treatment with Yttrium-90 microspheres. Aust. N.Z. J. Surg. 1992; 62: 105-10.
-
(1992)
Aust. N.Z. J. Surg.
, vol.62
, pp. 105-110
-
-
Gray, B.N.1
Anderson, MA.2
Burton, G.3
-
7
-
-
0032742767
-
An initial experience with selective internal radiation therapy (SIRT) for non-resectable colorectal liver metastases
-
7. Stubbs RS, Cannan RJ, Mitchell AW, Alwan MH. An initial experience with selective internal radiation therapy (SIRT) for non-resectable colorectal liver metastases. Cancer Res. Treat. 1999; 3: 135-43.
-
(1999)
Cancer Res. Treat.
, vol.3
, pp. 135-143
-
-
Stubbs, R.S.1
Cannan, R.J.2
Mitchell, A.W.3
Alwan, M.H.4
-
8
-
-
0029987826
-
Arterial therapy of hepatic colorectal metastases
-
8. Vauthey JN, de Marsh RW, Cendan JC et al. Arterial therapy of hepatic colorectal metastases. Br. J. Surg. 1995; 83: 447-55.
-
(1995)
Br. J. Surg.
, vol.83
, pp. 447-455
-
-
Vauthey, J.N.1
De Marsh, R.W.2
Cendan, J.C.3
-
9
-
-
0032466334
-
Hepatic cryotherapy and subsequent hepatic arterial chemotherapy for colorectal metastases to the liver
-
9. Stubbs RS, Alwan MH, Booth MWC. Hepatic cryotherapy and subsequent hepatic arterial chemotherapy for colorectal metastases to the liver. HPB Surg. 1998; 11: 97-104.
-
(1998)
HPB Surg.
, vol.11
, pp. 97-104
-
-
Stubbs, R.S.1
Alwan, M.H.2
Booth, M.W.C.3
-
10
-
-
0027504513
-
Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices
-
10. Curley SA, Chase JL, Roh MS, Hohn DC. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993; 114: 928-35.
-
(1993)
Surgery
, vol.114
, pp. 928-935
-
-
Curley, S.A.1
Chase, J.L.2
Roh, M.S.3
Hohn, D.C.4
-
11
-
-
0022515406
-
Total hepatic arterial perfusion after occlusion of variant lobar vessels: Implications for hepatic arterial chemotherapy
-
11. Rayner AA, Kerlan RK, Stagg RJ et al. Total hepatic arterial perfusion after occlusion of variant lobar vessels: Implications for hepatic arterial chemotherapy. Surgery 1986; 99: 708-14.
-
(1986)
Surgery
, vol.99
, pp. 708-714
-
-
Rayner, A.A.1
Kerlan, R.K.2
Stagg, R.J.3
-
13
-
-
0029952268
-
Cryoablation of hepatic malignancy: An evaluation of tumour marker data and survival in 110 patients
-
13. Morris DL, Ross WB, Igbal J et al. Cryoablation of hepatic malignancy: An evaluation of tumour marker data and survival in 110 patients. GI Cancer 1996; 1: 247-51.
-
(1996)
GI Cancer
, vol.1
, pp. 247-251
-
-
Morris, D.L.1
Ross, W.B.2
Igbal, J.3
-
14
-
-
0029166591
-
Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy
-
14. Preketes AP, Caplehorn JRM, King J et al. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J. Surg. 1995; 19: 768-71.
-
(1995)
World J. Surg.
, vol.19
, pp. 768-771
-
-
Preketes, A.P.1
Caplehorn, J.R.M.2
King, J.3
-
15
-
-
0029151386
-
Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases
-
15. Burke D, Earlam S, Fordy C, Allen-Mersh TG. Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases. Br. J. Surg. 1995; 82: 1098-100.
-
(1995)
Br. J. Surg.
, vol.82
, pp. 1098-1100
-
-
Burke, D.1
Earlam, S.2
Fordy, C.3
Allen-Mersh, T.G.4
-
16
-
-
0029943368
-
Response to regional chemotherapy in patients with variant hepatic arterial anatomy
-
16. Doughty JC, Warren H, Anderson JH et al. Response to regional chemotherapy in patients with variant hepatic arterial anatomy. Br. J. Surg. 1996; 83: 652-3.
-
(1996)
Br. J. Surg.
, vol.83
, pp. 652-653
-
-
Doughty, J.C.1
Warren, H.2
Anderson, J.H.3
-
17
-
-
0030443726
-
Major upper gastrointestinal haemorrhage associated with hepatic arterial chemoperfusion
-
17. Ross WB, Morris DL, Clingan PR. Major upper gastrointestinal haemorrhage associated with hepatic arterial chemoperfusion. Aust. N.Z. J. Surg. 1996; 66: 816-19.
-
(1996)
Aust. N.Z. J. Surg.
, vol.66
, pp. 816-819
-
-
Ross, W.B.1
Morris, D.L.2
Clingan, P.R.3
|